- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07368699
Active Oxygen Releasing Gel With Photodynamic Therapy in Treating Stage III Periodontitis
Evaluation of Active Oxygen Releasing Gel Combined With Photodynamic Therapy in The Treatment of Stage III Periodontitis (A Randomized Controlled Clinical Trial)
Periodontitis is a serious gum disease that can damage the tissues supporting the teeth. The standard treatment is scaling and root planing of the teeth and roots. However, in some patients, this treatment alone may not fully control inflammation and harmful bacteria.
This study aims to evaluate whether adding an active oxygen-releasing gel, with or without photodynamic therapy, improves treatment outcomes in patients with stage III periodontitis. The oxygen-releasing gel is applied to the gums and releases oxygen, which may help reduce harmful bacteria. Photodynamic therapy uses a light source together with a special dye to target and destroy bacteria and improve gingival health.
In this randomized clinical trial, 42 patients with stage III periodontitis will be divided into three groups. One group will receive standard scaling and root planing (SRP) plus the oxygen-releasing gel. A second group will receive standard scaling and root planing (SRP)plus the gel and photodynamic therapy. The third group will receive standard scaling and root planing(SRP) only.
Gum health will be evaluated by measuring gingival index, bleeding index, pocket depth, and supra crestal tissue attachment level at the start of the study and after one and three months. Microbiological samples from periodontal pockets will also be used to assess levels using quantitative Polymerase Chain Reaction (qPCR) for relative abundance of Treponema denticola and Porphyromonas gingivalis bacteria related to periodontal disease.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Aya Abdelmawla, BDS
- Phone Number: +201128192575
- Email: aia.abdelmoula.2019@gmail.com
Study Contact Backup
- Name: Aliaa Gamaleldin Aboulela, PhD
- Phone Number: +20 10 02104138
Study Locations
-
-
Bab Sharq
-
Alexandria, Bab Sharq, Egypt, 21578
- Recruiting
- Faculty of Dentistry, Alexandria University
-
Contact:
- Faculty of Dentistry, Alexandria University
- Phone Number: +2034868066
- Email: dent.admin@alexu.edu.eg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with periodontal diagnosis of stage III periodontitis
- Patients with residual periodontal pocket depth ≥4 mm ,CAL≥ 5mm with bone loss extending to middle third of root and beyond in radiography
- Bleeding on probing at least four sites at base-line
- Patients who didn't receive periodontal treatment for a minimum of 3 months prior to the examination.
- Patients of both sexes aged ≥30 and ≤70 years
Exclusion Criteria:
- Smokers or those with any other harmful habits such as pipe or vape smoking
- Patients with any systemic condition that will possibly affect the outcome of periodontal therapy i.e. (diabetic patients)
- Patients who have received any local or systemic anti-inflammatory medications or antibiotics within the last 6 months
- Pregnant or lactating women
- Patients with parafunctional habits
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SRP+Active oxygen gel.
Scaling and root planing(SRP)followed by topical application of active oxygen-releasing gel (0.4 mL) for 3 minute
|
14 patients with stage III periodontitis will undergo scaling and root planing in a single session followed by topical application of active oxygen-releasing gel (0.4 mL) for 3 minutes.
14 patients will undergo scaling and root planing(SRP) using ultrasonics and Gracey curettes.
|
|
Experimental: SRP+ Oxygen gel+Laser
Scaling and root planing (SRP) will be performed in a single session, followed by the topical application of active oxygen-releasing gel (0.4 mL) for 3 minutes.
Subsequently, antimicrobial Photodynamic Therapy (aPDT) will be applied using a diode laser (635 nm) with tolonium chloride as a photosensitizer.
The laser irradiation will be performed at an energy density of 6 J/cm2 for 30 seconds per site."
|
14 patients with stage III periodontitis will undergo scaling and root planing in a single session followed by topical application of active oxygen-releasing gel (0.4 mL) for 3 minutes.
14 patients will undergo scaling and root planing(SRP) using ultrasonics and Gracey curettes.
14 stage III periodontitis patients will undergo scaling and root planing in a single session followed by topical application of active oxygen-releasing gel (0.4 mL) for 3 minutes then irrigating the targeted pocket using tolonium chloride will be stopped once the tolonium chloride solution will be observed at the free gingival margin of the pocket.
After 60 seconds, irradiation inside the periodontal pocket with diode laser (635nm) for 200 mW, 30 seconds, energy density of 6 J/cm2, tip diameter of 400 µm, using continuous modes of irradiation, the laser fiber tip will be positioned parallel to the long axis of the tooth, move in a steady vertical inward and outward motion to ensure that the entire pocket will be adequately covered.
|
|
Active Comparator: Scaling and root planing alone.
Scaling and root planing using ultrasonics and Gracey curettes.
|
14 patients will undergo scaling and root planing(SRP) using ultrasonics and Gracey curettes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Gingival Index (MGI) score
Time Frame: Before enrollment, and one and three months after enrollment
|
non-invasive, visual clinical tool (0-4 scale)focuses on color, texture, and contour changes across facial, lingual, mesial, and distal surfaces of tooth ,modified gingival Scoring Criteria for MGI (0-4) higher scores indicate more severe gingival inflammation higher a worse clinical outcome. 0: Absence of inflammation (normal gingiva).
|
Before enrollment, and one and three months after enrollment
|
|
Percentage of sites with Bleeding on Probing (BOP) assessed by a periodontal probe
Time Frame: Before enrollment, and one and three months after enrollment
|
a clinical parameter measured by inserting a periodontal probe to the base of a gingival pocket.The probe is inserted parallel to the root surface and "walked" around the gingival sulcus, with bleeding assessed 30-60 seconds after probing.recorded as a percentage of positive bleeding sites out of the total sites probed (6 sites per tooth).
A higher percentage of bleeding sites indicates increased gingival inflammation and a worse outcome.
|
Before enrollment, and one and three months after enrollment
|
|
Measurement of Clinical Attachment Level (CAL) using a Williams calibrated periodontal probe
Time Frame: Before enrollment, and one and three months after enrollment
|
measured in millimeters using Williams calibrated probe from the cemento-enamel junction to the bottom of the pocket .This measure reflects the extent of periodontal tissue destruction.
Higher values in millimeters indicate greater attachment loss and a worse clinical condition.
|
Before enrollment, and one and three months after enrollment
|
|
Probing Pocket Depth (PPD) in millimeters measured by Williams periodontal probe
Time Frame: Before enrollment, and one and three months after enrollment
|
Clinical measurement of the distance in millimeter from the gingival margin to the base of the periodontal pocket using Williams calibrated probe.Deeper pockets indicate more severe periodontal disease.
Higher values represent a worse outcome.
|
Before enrollment, and one and three months after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relative abundance of Treponema denticola and Porphyromonas gingivalis using quantitative Polymerase Chain Reaction (qPCR)
Time Frame: Before enrollment and one month after enrollment
|
Sub-gingival dental plaque biofilm (before the intervention and one month after the intervention) will be collected using size 30 paper point after ensuring good isolation of the operating field.
quantitative real time PCR will be performed using universal bacterial 16SrRNA gene primers and species-specific primers targeting the 16S rRNA genes of Treponema denticola (Td), and Porphyromonas gingivalis (Pg), to estimate the relative abundance of Td and Pg among total oral microbiota before and after treatment
|
Before enrollment and one month after enrollment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mohey eldin Elrashidy, PhD,prof, Faculty of Dentistry periodontology department Alexandria University,Egypt.
- Study Director: Tarek Alsahry, Phd, Faculty of Dentistry periodontology department Alexandria University,Egypt.
- Study Director: Aliaa Gamaleldin Aboulela, PhD, Microbiology Department ,Medical Research Institute Alexandria University,Egypt
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1016-12/2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stage III Periodontitis
-
Misr University for Science and TechnologyCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Shanghai Ninth People's Hospital Affiliated to...Not yet recruitingPeriodontitis Stage II | Periodontitis Stage III | Periodontitis Stage IV
-
Cairo UniversityRecruitingPeriodontitis | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Gülnur EmingilEge University Scientific Research Projects Coordination UnitCompletedPeriodontitis (Stage 3) | Periodontitis Stage IIITurkey (Türkiye)
-
Cairo UniversityNot yet recruitingStage II or Stage III Grade B PeriodontitisEgypt
-
Hagar Ahmed Ali Mohammed ElzainMansoura UniversityActive, not recruiting
-
Nada Mahmoud SolimanRecruitingStage III PeriodontitisEgypt
-
Ataturk UniversityActive, not recruitingStage III PeriodontitisTurkey (Türkiye)
-
Alparslan DilsizCompletedPeriodontitis | Stage III PeriodontitisTurkey (Türkiye)
-
Ataturk UniversityCompletedPeriodontitis | Periodontal Pocket | Stage IV Periodontitis | Stage III Periodontitis | Residual Periodontal PocketTurkey (Türkiye)
Clinical Trials on Scaling and root planing and topical application of active oxygen-releasing gel
-
Institut Straumann AGCompleted
-
Tree of Life Pharma Ltd.Completed
-
King Saud UniversityZiauddin UniversityUnknownChronic Periodontitis
-
KLOX Technologies Inc.CompletedModerate to Severe Chronic PeriodontitisCanada
-
Tanta UniversityActive, not recruitingChronic PeriodontitisEgypt
-
Case Western Reserve UniversityOraPharmaRecruitingPeriodontitis, Diabetes Mellitus Type 2United States
-
Sterify S.r.l.Sciently di Omar SabryCompleted
-
Kafrelsheikh UniversityNot yet recruitingChronic Periodontitis | Stage II, Grade B Periodontitis
-
University of BaghdadNot yet recruiting
-
University of SalamancaCompletedPeriodontal Disease | Periodontal InflammationSpain